Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Acquisitions (2021 - 2022)

Beauty Health (SKIN) has disclosed Acquisitions for 2 consecutive years, with -$2.5 million as the latest value for Q3 2022.

  • Quarterly Acquisitions fell 114.13% to -$2.5 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $15.4 million through Dec 2022, up 650.5% year-over-year, with the annual reading at $22.9 million for FY2021, N/A changed from the prior year.
  • Acquisitions for Q3 2022 was -$2.5 million at Beauty Health, down from $18.0 million in the prior quarter.
  • The five-year high for Acquisitions was $18.0 million in Q3 2021, with the low at -$20.8 million in Q2 2021.